What is a white-hot market in healthcare tech? Governance, risk and compliance (GRC), says Bill Watts, who leads the healthcare tech group at Brown Gibbons Lang & Company. He also lists supply chain for pharma and drug commercialization and employer tech.
In this conversation with McGuireWoods partner and host Geoff Cockrell, Bill unpacks how today's health tech investment landscape has evolved post-pandemic, with investors pursuing different strategies as deal volume normalizes.
Tune in for his insights about mixed business models, deal activity so far this year and the commercial prospects for AI.
Connect and Learn More
☑️ Bill Watts | LinkedIn
☑️ Brown Gibbons Lang & Company | LinkedIn | X
☑️ Geoff Cockrell | LinkedIn
☑️ McGuireWoods | LinkedIn | Facebook | Instagram | X
☑️ Subscribe Apple Podcasts | Spotify | Amazon Music
This podcast was recorded and is being made available by McGuireWoods for informational purposes only. By accessing this podcast, you acknowledge that McGuireWoods makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in the podcast. The views, information, or opinions expressed during this podcast series are solely those of the individuals involved and do not necessarily reflect those of McGuireWoods. This podcast should not be used as a substitute for competent legal advice from a licensed professional attorney in your state and should not be construed as an offer to make or consider any investment or course of action.
